Michael J. Fox Won’t Budge on Stem Cell Research After Breakthrough

Bioethics   |   Steven Ertelt   |   Dec 9, 2007   |   9:00AM   |   WASHINGTON, DC

Michael J. Fox Won’t Budge on Stem Cell Research After Breakthrough Email this article
Printer friendly page

by Steven Ertelt
LifeNews.com Editor
December 9,
2007

Washington, DC (LifeNews.com) — Prominent embryonic stem cell research proponent Michael J. Fox won’t change his views on the controversial science following an ethical breakthrough. Scientists in Wisconsin and Japan discovered a way of converting adult skin cells into an embryonic-like state.

They also were able to overcome other hurdles associated with the embryonic-like cells to show that they are not only more ethical than embryonic ones but more effective as well.

When asked by NBC’s Maria Menounos whether the news has changed Fox’s mind, he refused to abandon the practice of embryo destruction.

"We don’t want to discontinue the embryonic stem cell research that’s being done because one begat the other and, and it all becomes part of a broad canvas that we want to continue to work on," he said.

With regard to ending the debate over embryonic stem cell research and destroying human life to advance science, Fox said, "I want to make sure that we, that, that doesn’t happen."

Instead of embracing the news that scientists can use embryonic-like cells without destroying human life, Geoffrey Dickens writes at the Newsbusters blog that Fox went after President Bush.

"Even as scientific advancements on stem cell research have vindicated George W. Bush’s resistance to destroy actual embryos, Michael J. Fox refused to give the president any credit," Dickens wrote on the Media Research Center’s blog.

Instead, Dickens says Fox "chose to indirectly insult him."

Fox declared that, after the 2008 presidential elections, "the chances are very good that there’s gonna be a new attitude towards science."

The actor, who has been criticized for ads twisting the views of pro-life candidates, said he would back the candidate after the primaries who has the most friendly view towards embryonic stem cell research.